The Holy Grail of Cardiology - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

The Holy Grail of Cardiology

Description:

The 1st Guideline of Association for Eradication of Heart Attack (AEHA) for ... Verheye et al. Circulation Supple Oct. 2001; Disclosure: Volcano Therapeutics, Inc. ... – PowerPoint PPT presentation

Number of Views:42
Avg rating:3.0/5.0
Slides: 38
Provided by: mohammad4
Category:

less

Transcript and Presenter's Notes

Title: The Holy Grail of Cardiology


1
The Holy Grail of Cardiology
Vulnerable Plaques
2
From Vulnerable Plaques to Vulnerable Patients
  • The 1st Guideline of Association for Eradication
    of Heart Attack (AEHA) for Definition of
    Vulnerable Plaque and Vulnerable Patient
  • (VP.org)

Morteza Naghavi, Erling Falk, Mohammad Madjid,
Silvio Litovsky, Ward Casscells, Renu Virmani,
James T. Willerson
3
1.5 millions in the US
4
(No Transcript)
5
Underlying pathologies of culprit coronary
lesions
  • Ruptured Plaques (70)
  • Stenotic (20)
  • Non-stenotic (50)
  • Non-Ruptured Plaques ( 30)
  • Erosion
  • Calcified Nodule
  • Others / Unknown

MJ Davies, Circ. 1990 Falk et al. Circ. 1995
Virmani et al. ATVB 2000
6
  •  Terminology
  • Culprit Plaque
  • a Retrospective Terminology
  • Vulnerable Plaque
  • a Prospective Terminology

7
Vulnerable Plaque
  • Plaques with high likelihood of thrombosis or
    rapid progress

8
Interchangeable Terminologies
9
(No Transcript)
10
Proposed Histopathological and Clinical Criteria
for Definition of Vulnerable Plaque
  •  Major Criteria
  • Active Inflammation (monocyte/ macrophage
    infiltration)
  • Thin Cap with Large Lipid Core
  • Endothelial Denudation with Superficial Platelet
    Aggregation
  • Fissured / Wounded Plaque

11
Proposed Histopathological and Clinical Criteria
for Definition of Vulnerable Plaque
  •  Minor Criteria
  • Superficial Calcified nodule
  • Glistening Yellow
  • Intraplaque Hemorrhage
  • Critical Stenosis
  • Positive Remodeling?

12
Ideal method for screening vulnerable
plaque/patient
  • Non-invasive
  • Inexpensive
  • Accurate
  • Widely Reproducible

13
Proposed Histopathological and Clinical Criteria
for Definition of Vulnerable Plaque
  •  Major Criteria
  • Active Inflammation (monocyte/ macrophage
    infiltration)
  • Thin Cap with Large Lipid Core
  • Endothelial Denudation with Superficial Platelet
    Aggregation
  • Fissured / Wounded Plaque

14
Thermography a Novel Approach for Identification
of Vulnerable Plaques
  • Mohammad Madjid, MD,
  • Ward Casscells, MD,
  • James T. Willerson, MD,
  • Morteza Naghavi, MD

15
Cardinal Signs of Inflammation
16
Hypothesis
  • Vascular inflammation and plaque vulnerability
    can be identified by the heat released from
    activated macrophages in the plaque.

17
Temperature heterogeneity over the surface of an
endartherectomized carotid plaque
Casscells W et al. Lancet. 19963471447-51
18
While macrophage/monocytes (with high metabolic
rate) density was related to higher temperature,
such a relation wasnt seen with smooth muscle
cell density (with less metabolic activity)
19
Inverse relation between temperature difference
and cap thickness
20
Infrared experiments show temperature
heterogeneity
Our dog model of atherosclerosis develops marked
lesions in its coronary arteries (left panel). We
observed significant temperature heterogeneity
along the coronary arteries of these dogs using
an infrared camera (right panel).
An infrared camera image shows marked temperature
heterogeneity over the surface of an
atherosclerotic carotid plaque
21
Inverse correlation of pH and temperature (ºC)
in endartherectomized human carotid artery
plaques
Naghavi et al. Atherosclerosis, 2002, in press
22
In vivo Studies
23
Thermosensor Basket Catheter
24
(No Transcript)
25
Dog Model of Atherosclerosis
Femoral Artery Atherosclerotic With Temperature
Heterogeneity
Carotid Artery Non-Atherosclerotic Without
Temperature Heterogeneity
26
Plt0.05
Higher absolute temperature as well as
temperature heterogeneity in femoral arteries of
atherosclerotic dogs compared to their carotid
arteries which are free of disease.
27
Temperature heterogeneity in atherosclerotic
lesions of Watabae rabbits
No temperature heterogeneity In aortae of normal
mice
Temperature heterogeneity In aortae of
atherosclerotic mice
28
Infrared angio-thermography catheter
29
Human Studies
  • Our findings have been confirmed in clinical
    settings by the Hellenic group of Stefandis and
    colleagues, and also in Belgium and the
    Netherlands.

30
In vivo thermal heterogeneity within human
atherosclerotic coronary arteries
Stefanadis et al. Circulation. 1999991965-71
31
The risk of an adverse cardiac event in patients
with high temperature difference is significantly
higher than that in ACS patients with low
temperature difference
Stefanadis et al. J Am Coll Cardiol.
2001371277-83
32
Strong correlation between C-reactive protein
(CRP) (and serum amyloid A (SAA) ) and the
temperature differences
Stefanadis et al. J Mol Cell Cardiol.
20003243-52
33
  • Administration of atorvastatin in patients with
    coronary artery disease results in less heat
    production from the culprit lesion and less
    temperature difference.

Stefanadis et al. Eur Heart J (in press)
34
  • Toutozas et al reported correlation between
    temperature and expansive remodeling and MMP-9
    concentration
  • Verheye et al showed significant temperature
    heterogeneity in cholesterol fed rabbits which
    was reduced after changing from high to
    low-cholesterol diet in rabbits.

Toutouzas et al. Circulation. 2000102II-707
Toutouzas et al. J Am Coll Cardiol.
200137356A Verheye et al. Circulation Supple
Oct. 2001
35
Disclosure
  • Volcano Therapeutics, Inc.

36
ThermaStar Catheter
Not cleared by the FDA and not available for
commercial sale.
37
Center for Vulnerable Plaque ResearchHouston,
Texas
Khawar Gul, MD Said Siadaty, MD Sameh Naguib,
MD Bujin Gu, PhD Reji John, MD Basit Malik, MD KC
Courian, MD Roxana Grausu, MD
Mohammad Madjid, MD, Ward Casscells, MD, James
T. Willerson, MD, Morteza Naghavi, MD
Write a Comment
User Comments (0)
About PowerShow.com